pe
pep-05435 v1 CC-BY-SA-4.0

Viral envelope gp160 HIV-fighting peptide

A lab-made antiviral peptide studied for its ability to fight HIV; experimental, not yet an approved drug.

statusbioassayed targetANTIMICROBIAL length45 aa refs2
anti-hivantiviral
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.717
avg pLDDT94.3
ranking score0.898
STRUCTURE · PEP-05435 × ANTIMICROBIAL
ranking0.898
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence45 aa
151015202530354045
CDGGIKKEIEAIKKE QEAIKKKIEAIEKLL QLTVWGIKQLQARIL
in the news 6 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.8977059721946716 boltz-2
3-letter notation
Cys-Asp-Gly-Gly-Ile-Lys-Lys-Glu-Ile-Glu-Ala-Ile-Lys-Lys-Glu-Gln-Glu-Ala-Ile-Lys-Lys-Lys-Ile-Glu-Ala-Ile-Glu-Lys-Leu-Leu-Gln-Leu-Thr-Val-Trp-Gly-Ile-Lys-Gln-Leu-Gln-Ala-Arg-Ile-Leu
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Viral envelope gp160 HIV-fighting peptide (pep-05435, v1). PeptideModel. https://peptidemodel.com/card/pep-05435
@peptide{pep05435,
  sequence = {CDGGIKKEIEAIKKEQEAIKKKIEAIEKLLQLTVWGIKQLQARIL},
  target   = {antimicrobial},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 3 by signal overlap
references 2 papers
[1]
Enfuvirtide
Chen, R. et al. Expert Opinion on Investigational Drugs 2002
supporting
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use